Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data

Tytuł :
Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data
Autorzy :
Angela B Brueggemann, ProfDPhil
Melissa J Jansen van Rensburg, ProfDPhil
David Shaw, MD
Noel D McCarthy, ProfDPhil
Keith A Jolley, PhD
Martin C J Maiden, ProfPhD
Mark P G van der Linden, PhD
Zahin Amin-Chowdhury, BSc
Désirée E Bennett, PhD
Ray Borrow, PhD
Maria-Cristina C Brandileone, PhD
Karen Broughton, MSc
Ruth Campbell
Bin Cao, ProfMD
Carlo Casanova, PhD
Eun Hwa Choi, ProfMD
Yiu Wai Chu, PhD
Stephen A Clark, PhD
Heike Claus, PhD
Juliana Coelho, PhD
Mary Corcoran, PhD
Simon Cottrell, PhD
Robert J Cunney, MD
Tine Dalby, PhD
Heather Davies, NZCS
Linda de Gouveia, NatDipMicro
Ala-Eddine Deghmane, PhD
Walter Demczuk, BSc
Stefanie Desmet, PharmD
Richard J Drew, MD
Mignon du Plessis, PhD
Helga Erlendsdottir, ProfMSc
Norman K Fry, PhD
Kurt Fuursted, MD
Steve J Gray, PhD
Birgitta Henriques-Normark, ProfMD
Thomas Hale, PhD
Markus Hilty, PhD
Steen Hoffmann, MD
Hilary Humphreys, ProfMD
Margaret Ip, MD
Susanne Jacobsson, PhD
Jillian Johnston, MBBS
Jana Kozakova, MD
Karl G Kristinsson, ProfMD
Pavla Krizova, MD
Alicja Kuch, PhD
Shamez N Ladhani, MD
Thiên-Trí Lâm, MD
Vera Lebedova, MD
Laura Lindholm, MSc
David J Litt, PhD
Irene Martin, BSc
Delphine Martiny, ProfPhD
Wesley Mattheus, PhD
Martha McElligott, PhD
Mary Meehan, PhD
Susan Meiring, MBChB
Paula Mölling, PhD
Eva Morfeldt, PhD
Julie Morgan, HND
Robert M Mulhall, PhD
Carmen Muñoz-Almagro, ProfMD
David R Murdoch, ProfMD
Joy Murphy, BA Hons
Martin Musilek, PhD
Alexandre Mzabi, MD
Amaresh Perez-Argüello, MLT
Monique Perrin, MD
Malorie Perry, MSc
Alba Redin, BSc
Richard Roberts, MPH
Maria Roberts, BSc
Assaf Rokney, PhD
Merav Ron, PhD
Kevin J Scott, PhD
Carmen L Sheppard, PhD
Lotta Siira, PhD
Anna Skoczyńska, ProfPhD
Monica Sloan
Hans-Christian Slotved, PhD
Andrew J Smith, ProfPhD
Joon Young Song, MD
Muhamed-Kheir Taha, MD
Maija Toropainen, PhD
Dominic Tsang, MD
Anni Vainio, PhD
Nina M van Sorge, PhD
Emmanuelle Varon, MD
Jiri Vlach, PhD
Ulrich Vogel, ProfMD
Sandra Vohrnova, MD
Anne von Gottberg, PhD
Rosemeire C Zanella, PhD
Fei Zhou, PhD
Pokaż więcej
Temat :
Computer applications to medicine. Medical informatics
R858-859.7
Źródło :
The Lancet: Digital Health, Vol 3, Iss 6, Pp e360-e370 (2021)
Wydawca :
Elsevier, 2021.
Rok publikacji :
2021
Typ dokumentu :
article
Opis pliku :
electronic resource
Język :
English
ISSN :
2589-7500
Relacje :
http://www.sciencedirect.com/science/article/pii/S2589750021000777; https://doaj.org/toc/2589-7500
DOI :
10.1016/S2589-7500(21)00077-7
Dostęp URL :
https://doaj.org/article/f6fe24685f384a75a4df9fa551875158
Numer akcesji :
edsdoj.f6fe24685f384a75a4df9fa551875158
Czasopismo naukowe
Summary: Background: Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis, which are typically transmitted via respiratory droplets, are leading causes of invasive diseases, including bacteraemic pneumonia and meningitis, and of secondary infections subsequent to post-viral respiratory disease. The aim of this study was to investigate the incidence of invasive disease due to these pathogens during the early months of the COVID-19 pandemic. Methods: In this prospective analysis of surveillance data, laboratories in 26 countries and territories across six continents submitted data on cases of invasive disease due to S pneumoniae, H influenzae, and N meningitidis from Jan 1, 2018, to May, 31, 2020, as part of the Invasive Respiratory Infection Surveillance (IRIS) Initiative. Numbers of weekly cases in 2020 were compared with corresponding data for 2018 and 2019. Data for invasive disease due to Streptococcus agalactiae, a non-respiratory pathogen, were collected from nine laboratories for comparison. The stringency of COVID-19 containment measures was quantified using the Oxford COVID-19 Government Response Tracker. Changes in population movements were assessed using Google COVID-19 Community Mobility Reports. Interrupted time-series modelling quantified changes in the incidence of invasive disease due to S pneumoniae, H influenzae, and N meningitidis in 2020 relative to when containment measures were imposed. Findings: 27 laboratories from 26 countries and territories submitted data to the IRIS Initiative for S pneumoniae (62 837 total cases), 24 laboratories from 24 countries submitted data for H influenzae (7796 total cases), and 21 laboratories from 21 countries submitted data for N meningitidis (5877 total cases). All countries and territories had experienced a significant and sustained reduction in invasive diseases due to S pneumoniae, H influenzae, and N meningitidis in early 2020 (Jan 1 to May 31, 2020), coinciding with the introduction of COVID-19 containment measures in each country. By contrast, no significant changes in the incidence of invasive S agalactiae infections were observed. Similar trends were observed across most countries and territories despite differing stringency in COVID-19 control policies. The incidence of reported S pneumoniae infections decreased by 68% at 4 weeks (incidence rate ratio 0·32 [95% CI 0·27–0·37]) and 82% at 8 weeks (0·18 [0·14–0·23]) following the week in which significant changes in population movements were recorded. Interpretation: The introduction of COVID-19 containment policies and public information campaigns likely reduced transmission of S pneumoniae, H influenzae, and N meningitidis, leading to a significant reduction in life-threatening invasive diseases in many countries worldwide. Funding: Wellcome Trust (UK), Robert Koch Institute (Germany), Federal Ministry of Health (Germany), Pfizer, Merck, Health Protection Surveillance Centre (Ireland), SpID-Net project (Ireland), European Centre for Disease Prevention and Control (European Union), Horizon 2020 (European Commission), Ministry of Health (Poland), National Programme of Antibiotic Protection (Poland), Ministry of Science and Higher Education (Poland), Agencia de Salut Pública de Catalunya (Spain), Sant Joan de Deu Foundation (Spain), Knut and Alice Wallenberg Foundation (Sweden), Swedish Research Council (Sweden), Region Stockholm (Sweden), Federal Office of Public Health of Switzerland (Switzerland), and French Public Health Agency (France).

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies